Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. - Wikidata - awgldk - TriplyDB

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

http://www.wikidata.org/entity/Q34209982

about

Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6 AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene SRC-3 has a role in cancer other than as a nuclear receptor coactivator.Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode Network-assisted protein identification and data interpretation in shotgun proteomics.SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells.Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer.Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells.MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy Expression of AIB1 protein as a prognostic factor in breast cancer Mouse models of estrogen receptor-positive breast cancer NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.The role of AIB1 in breast cancer PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas.Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.Cancer genetics of epigenetic genes.Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK-eIF2α-ATF4 signalling in breast cancer.Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models.Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.WWOX gene and gene product: tumor suppression through specific protein interactions.The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.Molecular Pathways: Targeting Steroid Receptor Coactivators in Cancer.The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.Genome-scale regression analysis reveals a linear relationship for promoters and enhancers after combinatorial drug treatment.

P2860

Q24300274-5F363FBD-2E01-4776-BF10-65668D4D4C06 Q24651305-E6228E44-C790-468C-8E52-6358565574D2 Q27687681-D40CB42E-A339-4331-AB20-2D029E5FB5E1 Q27852024-183B46C4-F89A-4C57-BF0A-A56625F0E367 Q28119116-F10BF86A-F6A0-4145-9E71-22C95FBA7A41 Q29028715-1CDB62F8-C66B-414F-9921-50F910420C52 Q33494813-EFA2DBD2-E277-4658-9620-FA566B2C855B Q33791097-85FCDC81-0EFE-46DA-8E96-5034E7129527 Q33912469-26D331FE-B9B5-402C-AA07-2859226D81AB Q33968214-B09E7925-2DBF-466F-A74D-FE2B0D60C20F Q34013708-6104CF13-F6DE-4372-887A-DBD1F60B1146 Q34286419-3E1C0A92-A86D-4945-95E1-D559EBBDAF1A Q34332205-A6A2D0C6-4392-45BB-B4C7-814764E33F35 Q34373935-6B05F53C-C409-4791-9066-D75ABB937F3C Q34529354-21EA7BCC-36B2-4323-BB45-6098D47EB300 Q34579190-9D95331F-F94F-4826-B86A-571FF08650B0 Q34921964-FD59909F-BFA3-40D6-8EC4-C0D9CEB6FFDC Q34946215-B79A5EF9-96D0-4BD1-ABA8-D2E7A11DDE78 Q35088231-CACD307C-C928-4048-BD33-6C6F6004C2F0 Q35456938-3B154CC5-63C2-49A2-91BA-F42BE6A67253 Q35605383-3D429722-7FA9-46D8-A6F6-3D50EDC07EF7 Q35685892-8EB5F5AB-545B-4DA6-9CA4-5F7626F54275 Q35768232-3E848B61-0F6C-49BF-AE0B-714C6CD69154 Q36423878-F6B4C701-C5D6-4CB2-8F08-D1C3CEFD0B54 Q36609982-8F36B7FA-10BA-4155-9475-4CE7B78911F5 Q36748207-E2B900CC-DA37-4FC5-AC5F-13259D9BFE28 Q36871595-CD444B7E-EB2D-4FE1-9BD9-B1A1652117F2 Q36935997-12057312-882E-453D-93C9-FDFC34D75915 Q37161861-D9287CA3-7E53-49C8-8175-D0C4A7035DCF Q37165437-4C544A5A-77B5-43B9-B4C7-24C34D1C7DB3 Q37316549-7CCF07FF-E05E-4CBE-8D13-239EDC4CACF3 Q37614521-0E871C94-C5F9-4AE8-B023-29C32FA553DF Q37644981-3C2EAA52-D86A-4545-97E6-62A0BB33B356 Q37690302-E384B839-4A48-45B7-B50A-E383EBAE0854 Q38820069-A7861EA1-4A0E-47C5-98B7-337B6680CE00 Q39207741-97412C39-98C1-4E64-90EE-D86CDAEF3348 Q43238522-DA36A6EA-1093-40B9-B9B0-7AB338A67203 Q43951760-754E2EE8-BD7B-4F93-84D4-06BD74036CBA Q47143778-1489CCB4-0348-4A60-8C9F-5F7140A438F3 Q47317874-73538753-85CD-4C2D-A0AB-132549AA8B19

P2860

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

http://www.wikidata.org/entity/Q34209982

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Elevated expression levels of ...... predictors of poor prognosis.

@ast

Elevated expression levels of ...... predictors of poor prognosis.

@en

Elevated expression levels of ...... predictors of poor prognosis.

@nl

type

label

Elevated expression levels of ...... predictors of poor prognosis.

@ast

Elevated expression levels of ...... predictors of poor prognosis.

@en

Elevated expression levels of ...... predictors of poor prognosis.

@nl

prefLabel

Elevated expression levels of ...... predictors of poor prognosis.

@ast

Elevated expression levels of ...... predictors of poor prognosis.

@en

Elevated expression levels of ...... predictors of poor prognosis.

@nl

P1433

Q34209982-7515C46C-CF0B-4812-84A0-71FB053BE055

P1476

Q34209982-D87A93DB-78E4-4186-8E97-05046298DAA0

P2093

Q34209982-2DFAB04D-7C99-4D73-8527-081F4E707568

Q34209982-4E654960-078F-44B3-85F3-357974D31DB3

Q34209982-5DAE36B9-B533-4096-B64A-996480328065

Q34209982-84185005-AC13-43BC-8696-441E4394BEAA

Q34209982-9AC80058-B42F-4887-B8FE-F18ADEDF4699

Q34209982-BCA4D8BF-52BC-4138-9D55-7B45DD29ABE7

Q34209982-F1B1F238-CB29-4CA5-8C8B-653812E91F0A

P304

Q34209982-F4F92F56-012F-4BDC-8C97-63F21825AE94

P31

Q34209982-7A679447-E3C6-4684-BA0D-904516EB339D

P356

Q34209982-282A7E1F-057D-4553-8DAB-55FB80734F9A

P407

Q34209982-C0334FA3-D7A8-416C-BAE7-B19EC6F13BEA

P433

Q34209982-B15EA2A0-5E1C-41CF-A659-4FB51394302D

P478

Q34209982-715397CB-9BA9-4A27-A988-166E53ABC0D2

P577

Q34209982-C42F2917-3BB0-4D11-83AF-613023F9A346

P5875

Q34209982-88AE4F99-10FF-4A95-9F5C-06AFB6D9DE42

P698

Q34209982-06F4B973-6853-43FA-81B3-F1469712FD31

P356

P1433

P1476

Elevated expression levels of ...... predictors of poor prognosis.

@en

P2093

Chen Zhao

http://www.w3.org/2001/XMLSchema#string

Chol Joo Lee

http://www.w3.org/2001/XMLSchema#string

Hideaki Kurioka

http://www.w3.org/2001/XMLSchema#string

Johji Inazawa

http://www.w3.org/2001/XMLSchema#string

Kohichiroh Yasui

http://www.w3.org/2001/XMLSchema#string

Takahiro Oka

http://www.w3.org/2001/XMLSchema#string

Youhei Hosokawa

http://www.w3.org/2001/XMLSchema#string

P304

18-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11482

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229669601

http://www.w3.org/2001/XMLSchema#string

P698

12833450

http://www.w3.org/2001/XMLSchema#string